The German biotech BioNTech SE has joined forces with Pfizer Inc to co-develop a candidate vaccine against infection from the coronavirus SARS-CoV-2 which had affected 1.7 million people globally as of 12 April and resulted in 105,952 deaths. ---Subscribe to MedNous to access this article--- Clinical Research Company News Finance, Grants, Deals
